SCHEMBL3827313

SCHEMBL3827313

O=P(O)(OC1CCCCC1)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.45
NPSR1 Q6W5P4 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CA1 P00915 5/20 0.33
CA2 P00918 5/20 0.33
MMP2 P08253 4/20 0.33
CA12 O43570 4/20 0.33
CA9 Q16790 4/20 0.33
MMP8 P22894 2/20 0.33
MMP1 P03956 2/20 0.33
MMP3 P08254 2/20 0.33
FDPS P14324 1/20 0.33
ANPEP P15144 2/20 0.32
ERAP2 Q6P179 2/20 0.32
INPP5A Q14642 1/20 0.32
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10947341 0.98 ACHE (0.44) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL11778949 0.78 ACHE (0.34) ACHECA1CA2MMP2CA12
SCHEMBL15106222 0.78 INPP5A (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL342838 0.78 INPP5A (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL18486452 0.78 ACHE (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL270557 0.78 ACHE (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL14412710 0.78 INPP5A (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL15105636 0.78 INPP5A (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL15105606 0.78 ACHE (0.50) ACHENPSR1MEN1KMT2ALMNA
SCHEMBL7041102 0.78 INPP5A (0.50) ACHENPSR1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1593705-B1 Use of organic phosphonic or phosphinic acids, or of oxides, hydroxides or carboxylic acid salts of metals as thermal stabilizers for polyhydroxyalcanoates METABOLIX INC (US) 2009-08-12 EP claimed
EP-2050785-A1 Use of organic phosphonic or phosphinic acids, or of oxides, hydroxides or carboxylic acid salts of metals as thermal stabilizers for plasticized polyhydroxyalcanoates Metabolix, Inc. (US) 2009-04-22 EP claimed
US-7208535-B2 PHA compositions and methods for their use in the production of PHA films METABOLIX, INC. (US) 2007-04-24 US claimed
EP-0996670-B1 PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS METABOLIX INC (US) 2006-05-31 EP claimed
EP-1593705-A1 Use of organic phosphonic or phosphinic acids, or of oxides, hydroxides or carboxylic acid salts of metals as thermal stabilizers for polyhydroxyalcanoates Metabolix, Inc. (US) 2005-11-09 EP claimed
US-20040039092-A1 PHA compositions and methods for their use in the production of PHA films METABOLIX, INC. 2004-02-26 US claimed
US-6620869-B2 Polyhydroxyalkanoate (PHA); pellets with high molecular weight PHA; forms films with good elongational and tensile properties METABOLIX, INC. 2003-09-16 US claimed
US-20020061944-A1 PHA compositions and methods for their use in the production of PHA films MONSANTO COMPANY 2002-05-23 US claimed
EP-0996670-A1 PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS MONSANTO COMPANY (US) 2000-05-03 EP claimed
WO-1999005207-A1 PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS MONSANTO COMPANY (US) 1999-02-04 WO claimed
WO-2023160577-A1 FUSED BICYCLIC COMPOUND CONTAINING PYRROLINONE 正大天晴药业集团股份有限公司 2023-08-31 WO disclosed
EP-3416205-B1 LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME SUMITOMO CHEMICAL CO (JP) 2021-03-17 EP disclosed
US-10711091-B2 Light-emitting device and method for producing same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2020-07-14 US disclosed
CN-108886106-B Light emitting element and method for manufacturing the same 住友化学株式会社 2020-05-19 CN disclosed
US-20190048131-A1 LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2019-02-14 US disclosed
EP-0996670-A1 PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS MONSANTO COMPANY (US) 2000-05-03 EP disclosed
WO-1999023146-A1 PLASTICIZED POLYHYDROXYALKANOATE COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF SHAPED POLYMERIC ARTICLES MONSANTO COMPANY (US) 1999-05-14 WO disclosed
WO-1999005207-A1 PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS MONSANTO COMPANY (US) 1999-02-04 WO disclosed
US-5418111-A Density; light sensitive elements; treating temperature dependency FUJI PHOTO FILM CO., LTD. (JP) 1995-05-23 US disclosed
EP-0622674-A1 Color diffusion transfer photographic material FUJI PHOTO FILM CO., LTD (JP) 1994-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10711091-B2 Light-emitting device and method for producing same SCO2, SUN2, SLC18A2 ACHE 758/4885NPSR1 3913/4885MEN1 2564/4885
US-20190048131-A1 LIGHT-EMITTING DEVICE AND METHOD FOR PRODUCING SAME SCO2, SUN2, SLC18A2 ACHE 758/4885NPSR1 3913/4885MEN1 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.